WYNZORA crème tb 60 g

7680689170015 CH-68917 D05AX52 10.03.0.

Reimbursement limitations:

WYNZORA

La durée maximale de remboursement du traitement est de 8 semaines.
Le remboursement est limité …

WYNZORA crème tb 60 g
WYNZORA crème tb 60 g
WYNZORA crème tb 60 g
1 / 3
google

Details

Product number
6891701
CPT
-
Packaging group
60
Unit
g
Composition
calcipotriolum 0.05 mg, betamethasonum 0.5 mg ut betamethasoni dipropionas, isopropylis myristas, paraffinum liquidum, triglycerida media, alcohol isopropylicus, macrogoli 4 aether laurilicus, poloxamerum 407, macrogolglyceroli hydroxystearas 3.37 mg, carbomerum interpolymerum A, E 320 1 mg, trolaminum, dinatrii phosphas heptahydricus, natrii dihydrogenophosphas monohydricus, E 307, aqua purificata q.s. ad unguentum pro 1 g.

Articles (1)

Wynzora 50 μg/g + 0.5 mg/g, Crème
Crème
60
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
04/06/2024
Professional SmPC
Français
04/06/2024
Professional SmPC
Italien
04/06/2024
Patient information leaflet
Allemand
03/06/2024
Patient information leaflet
Français
03/06/2024
Patient information leaflet
Italien
03/06/2024

Detailed composition

Substance Quantity Type Category
(N/A)
0.05 MG Substance Wirkstoff (Principe actif)
(N/A)
0.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.37 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
1.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance ANTON
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 58.65
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2024

Authorization holder

Almirall AG

8304 Wallisellen

Authorization information

Swissmedic authorization number
68917
Drug name
Wynzora, Crème
Galenic form
CREM
ATC Code
D05AX52
Authorization status
Z
Dispensation category
B
First authorization
10/10/2023
Authorization expiration date
09/10/2028
IT number
10.03.0.
Domain
Human medicine
Field of application
Psoriasis

Packaging details

Description (FR)
WYNZORA crème tb 60 g
Description (DE)
WYNZORA Creme Tb 60 g
Market launch
10/10/2023
Narcotic (BTM)
No

Available generics

Calcipotriol-Betamethason-Mepha, Salbe
CHF 35.90
View
Calcipotriol-Betamethason-Mepha, Salbe
CHF 50.70
View
CRYSALIS Leman, Pommade
CHF 30.10
View
CRYSALIS Leman, Pommade
CHF 40.55
View
CRYSALIS Leman, Pommade
CHF 56.35
View
Psotriol, Salbe
CHF 34.75
View
Psotriol, Salbe
CHF 50.70
View

Other packaging sizes

WYNZORA crème 2 tb 60 g
120 G
View